SAFEFLOW
Live / Applied — Suspended — suspension letter mailed (as of 11 Mar 2026)
What this means for you
Not registered yet, but its 15 May 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98551325
- Mark type
- Stylized text
- Filed
- 15 May 2024
- Attorney of record
- Mark Tetreault
Goods and services
- Class 010 — Medical apparatus: Medical devices being infusion devices, infusion flow control devices, and injection devices all for administering drugs and measured amounts of solutions over time; infusion sets comprised of infusion tubing specially adapted for medical apparatus being injection devices for administering drugs, infusion needles for medical use, needle guards, tubing connectors specially adapted for medical apparatus being injection devices for administering drugs, medical clips specially adapted for medical apparatus being injection devices for administering drugs, and structural parts therefor, sold as a unit
- Class 021 — Housewares and glass: Downloadable computer Software as a Medical Device (SaMD) for monitoring, adjusting, controlling, and coordinating infusion and injection devices and diagnostic settings based on customized data
Owner
- DEKA RESEARCH & DEVELOPMENT CORP., MANCHESTER, NH, US
Prosecution history
- 11 Mar 2026 — NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
- 11 Mar 2026 — LETTER OF SUSPENSION E-MAILED
- 11 Mar 2026 — SUSPENSION LETTER WRITTEN
- 28 Jan 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 28 Jan 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 28 Jan 2026 — TEAS REQUEST FOR RECONSIDERATION RECEIVED
- 23 Dec 2025 — NOTIFICATION OF FINAL REFUSAL EMAILED
- 23 Dec 2025 — FINAL REFUSAL E-MAILED
- 23 Dec 2025 — FINAL REFUSAL WRITTEN
- 01 May 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 01 May 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 01 May 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 31 Mar 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 31 Mar 2025 — NON-FINAL ACTION E-MAILED
- 31 Mar 2025 — NON-FINAL ACTION WRITTEN